SEARCH

SEARCH BY CITATION

References

  • Ahmed, M., Sternberg, A., Hall, G., Thomas, A., Smith, O., O’Marcaigh, A., Wynn, R., Stevens, R., Addison, M., King, D., Stewart, B., Gibson, B., Roberts, I. & Vyas, P. (2004) Natural history of GATA1 mutations in Down syndrome. Blood 103, 24802489.
  • Bozner, P. (2002) Transient myeloproliferative disorder with erythroid differentiation in Down syndrome. Arch. Pathol. Lab. Med. 126, 474477.
  • Calligaris, R., Bottardi, S., Cogoi, S., Apezteguia, I. & Santoro, C. (1995) Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. Proc. Natl Acad. Sci. USA 92, 1159811602.
  • Chang, A.N., Cantor, A.B., Fujiwara, Y., Lodish, M.B., Droho, S., Crispino, J.D. & Orkin, S.H. (2002) GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis. Proc. Natl Acad. Sci. USA 14, 92379242.
  • Dubart, A., Romeo, P.H., Vainchenker, W. & Dumenil, D. (1996) Constitutive expression of GATA-1 interferes with the cell-cycle regulation. Blood 87, 37113721.
  • Fujiwara, Y., Browne, C.P., Cunniff, K., Goff, S.C. & Orkin, S.H. (1996) Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl Acad. Sci. USA 93, 1235512358.
  • Greene, M.E., Mundschau, G., Wechsler, J., McDevitt, M., Gamis, A., Karp, J., Gurbuxani, S., Arceci, R. & Crispino, J.D. (2003) Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome. Blood Cells Mol. Dis. 31, 351356.
  • Harigae, H., Xu, G., Sugawara, T., Ishikawa, I., Toki, T. & Ito, E. (2004) The GATA1 mutation in an adult patient with acute megakaryoblastic leukemia not accompanying Down syndrome. Blood 103, 32423243.
  • Hitzler, J.K., Cheung, J., Li, Y., Scherer, S.W. & Zipursky, A. (2003) GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood 101, 43014304.
  • Hollanda, L.M., Lima, C.S., Cunha, A.F., Albuquerque, D.M., Vassallo, J., Ozelo, M.C., Joazeiro, P.P., Saad, S.T. & Costa, F.F. (2006) An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis. Nat. Genet. 18, 807812.
  • Holmes, D.K., Bates, N., Murray, M., Ladusans, E.J., Morabito, A., Bolton-Maggs, P.H., Johnston, T.A., Walkenshaw, S., Wynn, R.F. & Bellantuono, I. (2006) Hematopoietic progenitor cell deficiency in fetuses and children affected by Down’s syndrome. Exp. Hematol. 34, 16111615.
  • Ito, E., Kasai, M., Hayashi, Y., Toki, T., Arai, K., Yokoyama, S., Kato, K., Tachibana, N., Yamamoto, M. & Yokoyama, M. (1995) Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down’s syndrome. Br. J. Haematol. 90, 607614.
  • Ito, E., Toki, T., Ishihara, H., Ohtani, H., Gu, L., Yokoyama, M., Engel, J.D. & Yamamoto, M. (1993) Erythroid transcription factor GATA-1 is abundantly transcribed in mouse testis. Nature 362, 466468.
  • Karandikar, N.J., Aquino, D.B., McKenna, R.W. & Kroft, S.H. (2001) Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis. Am. J. Clin. Pathol. 116, 204210.
  • Kaushansky, K. (1995) Thrombopoietin: the primary regulator of platelet production. Blood 86, 419431.
  • Kuhl, C., Atzberger, A., Iborra, F., Nieswandt, B., Porcher, C. & Vyas, P. (2005) GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1. Mol. Cell. Biol. 25, 85928606.
  • Levine, R.F. & Fedorko, M.E. (1976) Isolation of intact megakaryocytes from guinea pig femoral marrow. Successful harvest made possible with inhibitions of platelet aggregation; enrichment achieved with a two-step separation technique. J. Cell Biol. 69, 159172.
  • Li, Z., Godinho, F.J., Klusmann, J.H., Garriga-Canut, M., Yu, C. & Orkin, S.H. (2005) Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat. Genet. 37, 613619.
  • Massey, G.V. (2005) Transient leukemia in newborns with Down syndrome. Pediatr. Blood Cancer 44, 2932.
  • Nishimura, S., Takahashi, S., Kuroha, T., Suwabe, N., Nagasawa, T., Trainor, C. & Yamamoto, M. (2000) A GATA box in the GATA-1 gene hematopoietic enhancer is a critical element in the network of GATA factors and sites that regulate this gene. Mol. Cell. Biol. 20, 713723.
  • Onodera, K., Takahashi, S., Nishimura, S., Ohta, J., Motohashi, H., Yomogida, K., Hayashi, N., Engel, J.D. & Yamamoto, M. (1997) GATA-1 transcription is controlled by distinct regulatory mechanisms during primitive and definitive erythropoiesis. Proc. Natl Acad. Sci. USA 94, 44874492.
  • Pan, X., Ohneda, O., Ohneda, K., Lindeboom, F., Iwata, F., Shimizu, R., Nagano, M., Suwabe, N., Philipsen, S., Lim, K.C., Engel, J.D. & Yamamoto, M. (2005) Graded levels of GATA-1 expression modulate survival, proliferation and differentiation of erythroid progenitors. J. Biol. Chem. 6, 2238522394.
  • Rainis, L., Bercovich, D., Strehl, S., Teigler-Schlegel, A., Stark, B., Trka, J., Amariglio, N., Biondi, A., Muler, I., Rechavi, G., Kempski, H., Haas, O.A. & Izraeli, S. (2003) Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood 102, 981986.
  • Shimizu, R., Engel, J.D. & Yamamoto, M. (2008) GATA1-related leukaemias. Nat. Rev. Cancer 8, 279287.
  • Shimizu, R., Kuroha, T., Ohneda, O., Pan, X., Ohneda, K., Takahashi, S., Philipsen, S. & Yamamoto, M. (2004a) Leukemogenesis caused by incapacitated GATA-1 function. Mol. Cell. Biol. 24, 1081410825.
  • Shimizu, R., Ohneda, K., Engel, J.D., Trainor, C.D. & Yamamoto, M. (2004b) Transgenic rescue of GATA-1-deficient mice with GATA-1 lacking a FOG-1 association site phenocopies patients with X-linked thrombocytopenia. Blood 103, 25602567.
  • Shimizu, R., Takahashi, S., Ohneda, K., Engel, J.D. & Yamamoto, M. (2001) In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis. EMBO J. 20, 52505260.
  • Takahashi, S., Onodera, K., Motohashi, H., Suwabe, N., Hayashi, N., Yanai, N., Nabesima, Y. & Yamamoto, M. (1997) Arrest in primitive erythroid cell development caused by promoter-specific disruption of the GATA-1 gene. J. Biol. Chem. 272, 1261112615.
  • Tober, J., Koniski, A., McGrath, K.E., Vemishetti, R., Emerson, R., De Mesy-Bentley, K.K., Waugh, R. & Palis, J. (2007) The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis. Blood 109, 14331441.
  • Ugazio, A.G., Maccario, R., Notarangelo, L.D. & Burgio, G.R. (1990) Immunology of Down syndrome: a review. Am. J. Med. Genet. Suppl. 7, 204212.
  • Vannucchi, A.M., Bianchi, L., Cellai, C., Paoletti, F., Rana, R.A., Lorenzini, R., Migliaccio, G. & Migliaccio, A.R. (2002) Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). Blood 100, 11231132.
  • Wechsler, J., Greene, M., McDevitt, M.A., Anastasi, J., Karp, J.E., Le Beau, M.M. & Crispino, J.D. (2002) Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat. Genet. 12, 15.
  • Weiss, M.J. & Orkin, S.H. (1995) Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc. Natl Acad. Sci. USA 92, 96239627.
  • Xu, M.J., Matsuoka, S., Yang, F.C., Ebihara, Y., Manabe, A., Tanaka, R., Eguchi, M., Asano, S., Nakahata, T. & Tsuji, K. (2001) Evidence for the presence of murine primitive megakaryocytopoiesis in the early yolk sac. Blood 97, 20162022.
  • Zipursky, A. (2003) Transient leukaemia – a benign form of leukaemia in newborn infants with trisomy 21. Br. J. Haematol. 120, 930938.